COIN:NASDAQCoinbase Global, Inc. Analysis
Data as of 2026-07-05 - not real-time
$165.48
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Coinbase’s stock is trading above its short‑term moving average but remains under the mid‑term average, indicating mixed momentum. The MACD line sits above its signal line, delivering a bullish technical signal despite an overall bearish trend direction. Momentum measured by the RSI hovers around the midpoint, suggesting neither overbought nor oversold conditions. Volatility has surged to levels far above the market norm, and the beta measurement confirms the share moves dramatically more than the broader index. The price is holding near a historically identified support zone while facing resistance just above the current level. Trading volume has been stable, providing sufficient liquidity but not enough to dampen price swings.
On the fundamentals side, revenue has contracted sharply year‑over‑year, and operating margins are in negative territory. The company nevertheless generates solid free cash flow and maintains a cash pile that comfortably exceeds its debt obligations. Valuation metrics such as the price‑to‑earnings multiple are markedly higher than the sector average, and the discounted‑cash‑flow model places intrinsic value well below the market price. Analyst consensus remains bullish, reflected in a “buy” recommendation, yet the market sentiment index is perched in the extreme greed zone, hinting at possible over‑optimism. Recent headlines point to both an expansion of product offerings and concerns about a waning retail moat and heightened regulatory scrutiny. Taken together, the stock appears overvalued in the near term, with upside limited by execution risk, but the strong balance sheet and emerging product line could provide a foundation for a longer‑run recovery.
On the fundamentals side, revenue has contracted sharply year‑over‑year, and operating margins are in negative territory. The company nevertheless generates solid free cash flow and maintains a cash pile that comfortably exceeds its debt obligations. Valuation metrics such as the price‑to‑earnings multiple are markedly higher than the sector average, and the discounted‑cash‑flow model places intrinsic value well below the market price. Analyst consensus remains bullish, reflected in a “buy” recommendation, yet the market sentiment index is perched in the extreme greed zone, hinting at possible over‑optimism. Recent headlines point to both an expansion of product offerings and concerns about a waning retail moat and heightened regulatory scrutiny. Taken together, the stock appears overvalued in the near term, with upside limited by execution risk, but the strong balance sheet and emerging product line could provide a foundation for a longer‑run recovery.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bullish MACD crossover
- price near support level
- elevated volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- strong cash position relative to debt
- potential revenue upside from new product suite
- price still above fair value but upside to intrinsic estimate
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- regulatory uncertainty in the crypto space
- high valuation relative to peers
- persistent revenue decline
Key Metrics & Analysis
Financial Health
Revenue Growth-30.80%
Profit Margin12.74%
P/E Ratio61.1
ROE6.69%
ROA1.93%
Debt/Equity59.08
P/B Ratio3.2
Op. Cash Flow$1.8B
Free Cash Flow$2.4B
Industry P/E17.5
Technical Analysis
TrendBearish
RSI50.8
Support$139.18
Resistance$176.48
MA 20$158.13
MA 50$178.84
MA 200$230.97
MACDBullish
VolumeStable
Fear & Greed Index93.2
Valuation
Fair Value$129.82
Target Price$229.14
Upside/Downside38.47%
GradeOvervalued
TypeValue
Risk Assessment
Beta3.06
Volatility66.97%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.